✦ LIBER ✦

Small Molecule Inhibitors of Dynamin I GTPase Activity: Development of Dimeric Tyrphostins

✍ Scribed by Graham, Mark E.; McGeachie, Andrew B.; Rusak, Jenny; Quan, Annie; Abagyan, Ruben; Scott, Janet L.; Robinson, Phillip J.; Hill, Timothy; Odell, Luke R.; Edwards, Jennifer K.

Book ID: 111679284
Publisher: American Chemical Society
Year: 2005
Tongue: English
Weight: 166 KB
Volume: 48
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm040208l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Iminochromene Inhibitors of Dynamins I a

Iminochromene Inhibitors of Dynamins I and II GTPase Activity and Endocytosis

✍ Hill, Timothy A.; Mariana, Anna; Gordon, Christopher P.; Odell, Luke R.; Roberts 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 918 KB

[Methods in Enzymology] Small GTPases in

[Methods in Enzymology] Small GTPases in Disease, Part A Volume 438 || Use of Dynasore, the Small Molecule Inhibitor of Dynamin, in the Regulation of Endocytosis

✍ Kirchhausen, Tom 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 307 KB

Development of Potent Non-Carbohydrate I

Development of Potent Non-Carbohydrate Imidazole-Based Small Molecule Selectin Inhibitors with Antiinflammatory Activity

✍ Slee, Deborah H.; Romano, Suzanne J.; Yu, Jinghua; Nguyen, Truc N.; John, Judy K 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 370 KB

Development of small-molecule inhibitors

Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer

✍ Chunling Yi; Jasna Maksimoska; Ronen Marmorstein; Joseph L. Kissil 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 373 KB

339 Development of HDAC Class I and II s

339 Development of HDAC Class I and II specific assays in order to identify novel small molecule inhibitors

✍ L.S. Collins; N. Khan; A. Finn; L.H. Jensen; F. McLaughlin; P.W. Finn; P. Buhl J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 146 KB

556 POSTER Novel small molecule inhibito

556 POSTER Novel small molecule inhibitors of Jak2/STAT3 pathway: design, structurte-activity relationship, and oral bioavilability

✍ W. Priebe; I. Fokt; S. Szymanski; Y. Bao; C. Conrad; A. Chakraborty; J. Abbruzze 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 81 KB